Introduction
In mammals, a very large Ig diversity (1) imposes mechanisms repertoires. In turn, studies of serum antibody and plasma cell repertoires have demonstrated the continuous positive that select the available repertoires of mature resting B cells and the actual repertoires of Ig-secreting plasmocytes from selection of a set of reactivities that is characteristic of normal individuals (13, 14) . the genetically determined repertoires emerging in the primary lymphoid organs (2,3). In the adult, all these sets of cells are
In order to approach the mechanisms of V-region-dependent B cell selection at the transition from the emergent to the renewed by the continuous production of B cells in the bone marrow (BM) (4) and the comparison of the cellular pool sizes available repertoire, we have studied the sensitivity to IgM ligation in BM and splenic B cells. As a model system, (5) indicates that only a very small fraction of the emergent repertoire is integrated into the mature compartments (6) we have used anti-µ inhibition of lipopolysaccharide (LPS)-induced differentiation of B cells into Ig-secreting cells (15, 16) . suggesting the operation of selection processes. Negative selection of B cells binding ligand with the required avidity This experimental system is suitable, since anti-µ antibodies bind to (and potentially inhibit) all IgM ϩ B cells and since LPS was directly confirmed in murine transgenic models (7, 8) . In normal mice, quantitation of expression of V H genes and can stimulate all B cells under our culture conditions (17, 18) . As previously reported (19, 20) , we also found that immature homology families in different B cell compartments (9) (10) (11) , as well as the analyses of 'multireactive' clonal frequencies (12) , B cells, present in new-born spleen and adult BM, are much more sensitive to inhibition of differentiation by anti-µ than have both shown that negative selection implicates a large fraction of cells between the emergent and the peripheral mature B cells from adult spleen. Furthermore, we have extended these findings of differential sensitivity to B cells In experiments involving pre-incubation of the newly differentiated cells (Fig. 7) , at day 2 of culture without IL-7, the present in peripheral blood and the peritoneal cavity, and to surface IgM ligation in the absence of Fc receptor engagemedium was supplemented with a supernatant (two-thirds final concentration) from bulk BM cultures (9ϫ10 6 cells/ml in ment. Using the phorbol ester phorbol myristate acetate (PMA), a direct activator of protein kinase C (PKC), which normal medium for 3 days) and further incubated for 2 more days. mimics anti-µ inhibition (21, 22) , we could show that the differences in sensitivity to anti-µ inhibition between splenic Antibodies and antigen. and BM B cells concern an early step of intracellular signaling, from surface IgM ligation to PKC activation.
The mAb used in this study have been described in (27) . MB86 (anti-µ b ), RS3.1 (anti-µ a ), b-7 6 (anti-µ), 187.1 (anti-κ L Finally, we have investigated the sensitivity to sIgM ligation of immature B cells generated in vitro from purified BM pre-B chain) and RA3-6B2 (anti-CD45R, anti-B220) were used either unlabeled or conjugated with biotin or FITC as indicated. cells and found that such cells are as resistant as are peripheral mature B cells, but recover levels of BM sensitivity Biotin-labeled goat anti-mouse IgM and monoclonal phycoerythrin (PE)-labeled anti-mouse IgD were purchased from upon incubation with supernatants of BM cell cultures. These observations question the notion that the sensitivity of newly Southern Biotechnology Associates (Birmingham, AL Flow cytometry mice were used at 6-20 weeks of age. Treatment with hydroxyurea (HU) was performed as described previously Flow cytometric analyses were performed as described before (24) : HU (Sigma, St Louis, MO) was dissolved in 0.9% NaCl (3,29). Briefly, single-cell suspensions of BM, spleen or periand administrated i.p. as two doses of 1 mg/g body wt/day, toneal cells were stained with FITC-labeled mAb (all anti-Ig injected 7 h apart for 4 days. reagents) and biotin-labeled mAb anti-B220, revealed by streptavidin-PE from Becton Dickinson (Grenoble, France).
Cells and cultures
Dead cells were excluded from analysis by using propidium Cell suspensions from spleen, BM and peritoneal cavity were iodide gating as described (29). Analyses were performed prepared as described earlier (3,6), and cultured at 10 5 cells/ on a FACScan (Becton Dickinson, Sunnyvale, CA) interfaced well in 0.2 ml flat-bottomed microtiter plates, containing to a Hewlett-Packard computer (HP900) using the FACScan different concentrations of antibodies or antigen together with research software programs. 6ϫ10 3 irradiated (2000 rad) S17 stromal cells (25, 26) were suspended in RPMI 1640 complete medium containing or 5 for cellular assays of Ig secretion (see below) and on 2% FCS and distributed to the microwells at appropriate day 7 for ELISA determination of secreted Ig accumulated in concentrations. The plates were incubated for 5-6 h at 37°C culture supernatants (see below).
in a humidified 5% CO 2 atmosphere and the cells thereafter removed by flicking the plate followed by lysis with 0.05% Culture of pre-B cells and generation of immature B cells Tween 20 in water. After extensive washing with PBS conin vitro.
taining 0.05% Tween 20, biotinylated goat anti-mouse IgM antibody was added into each well. After incubation and BM cells from adult C57BL/6 mice were cultured in the presence of recombinant mouse IL-7 (supernatant from J558-subsequent washing, streptavidin labeled with alkaline phosphatase (Southern Biotechnology Associates) was added and IL-7) and irradiated (2000 rad) S17 cells for 10 days. Remaining sIg ϩ cells were removed by panning (using goat the plates further incubated for an additional hour. After washing, the revealing substrate (2.3 mM of 5-bromo-4-chloroanti-mouse IgM). Thereafter the cells were allowed to differentiate for 3 days in the presence of S17 cells but in the absence 3-indolyl phosphate; Sigma) diluted in 2-amino-2-methyl-1-proprenolol buffer (Merck) was added. After incubation for of IL-7, resulting in a heterogeneous population of pre-B cells and sIgM ϩ B cells, the majority of which (85%) were immature 2 h at 37°C, the traces of Ig-secreting cells were revealed as blue spots and counted. For every test, duplicate dilution B cells as judged by high expression of sIgM and negative for sIgD.
series were used and the frequency of secreting cells was determined. In some experiments, after development and (27) . Second, the anti-µ antibody treatment does not affect proliferation induced by LPS in the same cultures where B counting, the blue spots were dissolved by adding 100 µl DMSO and the optical density at 650 nm (OD 650 ) was recorded cell differentiation to IgM secretion is completely suppressed (Fig. 1B) . Third, anti-µ inhibition is an 'all-or-none' phenomenon using an ELISA reader as described (31) .
at the single cell level. Thus, by using a modification of Spot-ELISA ELISA (31), which measures total IgM secreted by a given number of spot-forming cells, we could derive a slope repreCulture supernatants were assayed for IgM content with the senting the quantity of Ig produced per IgM-secreting B cell ELISA technique. ELISA plates that were coated overnight and thus ascertain whether or not anti-µ antibody treatment with b-7-6 antibodies (anti-µ), and then saturated with PBSaffects the rate of IgM secretion per cell. As can be seen in 1% gelatin, received dilution's of culture supernatants to be Fig. 1 (C), we obtained overlapping straight lines with data tested. After incubation (2 h, room temperature) and washing, from both control and anti-µ treated cultures which were peroxidase-labeled goat anti-mouse IgM antibodies were almost completely inhibited for the numbers of Ig-secreting added. After incubation (1 h, room temperature) and washing, cells. This strongly suggests that remaining secreting B cells bound antibodies were revealed with the substrate in inhibited cultures produce IgM at the same rate per cell o-phenylenediamine and H 2 O 2 . The reaction was stopped as B cells stimulated by LPS in the absence of anti-µ mAb. after 20 min by addition of 10% SDS and the absorbency We conclude that, in the presence of anti-µ mAb, LPSread at 450 nm in a Titertek multiscan spectrometer (Flow).
stimulated B cells seem to have only two alternatives: normal The concentration of IgM in culture supernatants were calcurate of secretion or no detectable secretion of IgM at all. In lated by using standard curves obtained with purified monoturn, this observation confirms that the respective cellular clonal IgM in the same assay.
controls operate at early stages in the activation process (15) . Proliferation These characteristics, as described for splenic B cells, also apply for B cells from the peritoneal cavity as well as for BM [ 3 H]Thymidine (Amersham, Buckinghamshire, UK; sp. act.
B cells (Fig. 1B and C) . 5 Ci/mmol) uptake was performed at the indicated times by adding 1 µCi per culture, 16 h before harvest. Pulsed cultures
The sensitivity to anti-µ inhibition varies among different B cell were harvested on glass-fiber filter papers using a Skatron populations 96-well microtiterplate harvester (Flow). After drying, the filters B cells from different organs were stimulated by LPS in the were immersed in scintillation fluid and counted in a Rack-Beta presence of increasing concentrations of monoclonal anti-µ Plate liquid scintillation counter (Pharmacia-LKB, Bromma, allotype antibodies and then tested by Spot-ELISA for Sweden). The data represent the mean of four cultures numbers of IgM-secreting cells after 4 days of culture. For expressed as c.p.m. per culture. The SEM never exceeded each population, the concentration of anti-µ mAb resulting in 10%.
a 50% inhibition of the control LPS response was evaluated (dotted line in Fig. 2 ). As can be seen in Fig. 2 , BM B cells Results from adult mice were 25 to 100 times more sensitive to anti-µ-mediated suppression of the LPS-induced terminal Characterization of the experimental model system maturation than were splenic B cells or peripheral blood B cells from the same animals. Furthermore, splenic B cells Since a variety of effects have been described for the action of anti-Ig reagents on B cell proliferation and differentiation from newborn animals were as sensitive as BM B cells from adult mice. As for adult spleen cells, the suppression is (15, 16, 20, 32, (33) (34) (35) , it was important to first characterize our experimental model system for IgM-dependent in vitro specific and does not concern proliferation. In addition, anti-B220 mAb at 10 µg/ml had no effect on the LPS stimulation inhibition of terminal differentiation.
B cells from different organs of C57BL/6 mice (IgM b allotype) of either B cell population. Similar results were obtained by employing ELISA tests, determining the total amount of IgM were incubated for 2 h with increasing doses of monoclonal anti-µ b or anti-µ a antibodies and then stimulated by LPS in secreted into culture supernatants (data not shown).
One possible explanation for this differential sensitivity to the continuous presence of the IgM ligand. After 2, 4 and 7 days respectively the cultures were tested for proliferation IgM ligation could be that the density and/or the total number of surface IgM molecules are different in these various B cell ([ 3 H]thymidine uptake), for differentiation to IgM-secreting cells (Spot-ELISA), as well as for total amounts of IgM populations. However, after direct staining with FITC-labeled anti-µ antibodies FACS analyses revealed broad profiles accumulated in the culture supernatants (ELISA). Three main findings should be stressed. First, anti-µ b (but not the anti-µ a ) where the differences in fluorescence intensities between the various B cell populations tested show considerable overlap antibodies inhibit LPS-induced differentiation of splenic B cells into high rate IgM-secreting cells. As shown in Fig. and thus can not alone account for the differential sensitivity to IgM ligation (3 and data not shown). 1(A), the number of IgM-secreting cells, as well as the concentrations of secreted IgM accumulated in the culture Different sensitivity to nominal antigen of splenic and BM B supernatants during 7 days, were markedly reduced at anti-µ b cells from the B6-SP6 transgenic mouse line antibody concentrations of 100 ng/ml and almost completely abolished at 1 µg/ml. The inability of anti-µ a to inhibit B cells
In the B6-SP6 line (23) , which is a C57BL/6 mouse (IgM b allotype) transgenic for a complete IgM a molecule derived from C57Bl/6 was specific, since this mAb preparation readily suppresses µ a -expressing B cells in similar experiments from a TNP-specific BALB/c hybridoma (36), Ͼ90% of the splenic and BM B cells express only the transgenic IgM a BM and splenic B cells show the same sensitivity to suppression by PMA molecule because of allelic exclusion (3). In such a mouse, therefore, anti-µ antibodies can be replaced by a non-antibody Since IgM ligation may mediate activation of PKC (38,39) ligand for surface IgM, represented by the nominal antigen the differential sensitivity described above could be due to TNP. If used in a multivalent form (TNP-BSA) to allow for variations in the relative levels of B cell PKC expression or cross-linking of surface IgM, this could give indications on activity. Since direct activation of PKC by phorbol esters the general physiological significance of IgM ligation. The (PMA) can mimic the inhibitory effects of anti-µ mAb on LPSresults from such an experiment are illustrated in Fig. 3, where induced B cell differentiation (21, 22) , we tested the sensitivity anti-µ mAb has been substituted by the antigen TNP-BSA.
of BM and splenic B cells to different concentrations of PMA. As can be seen, the LPS-induced terminal maturation of As can be seen in Fig. 4 , contrary to sIgM-ligation-dependent splenic B cells from B6-SP6 is~50 times more resistant to inhibition, splenic and BM B cells stimulated by LPS display inhibition by nominal antigen than BM B cells from the similar sensitivity to inhibition by PMA. Furthermore, in bulk same mouse. These observations strongly suggest that the cultures of LPS-stimulated spleen cells, anti-µ mAb at 5 µg/ml differential sensitivity to anti-µ of BM and splenic B cells or PMA at 5 ng/ml resulted in 10-20% enhanced numbers of applies to all ligands binding (and cross-linking) surface IgM. activated B cell blasts as compared to cultures receiving LPS Furthermore, this experimental strategy excludes that the alone. However, Ͻ1% of these blasts secreted IgM to form a differences recorded are due to different levels of Fc receptor spot (data not shown). If IgM ligation indeed results in expression in the various B cell populations. Finally, since PKC activation, these findings suggest that comparable IgM transgenic B cells lack surface IgD (3,37), the findings ligation in BM and splenic B cells results in different levels of demonstrate that both induction and suppression of B cell PKC activation. Thus, B cell populations may differ, with differentiation may occur in the absence of IgD expression, respect to signals generated by surface IgM ligation, and this difference is then located at an early point after ligand binding and are actually regulated independently of such receptors. Differential sensitivity of B cell populations is currently linked with the respective maturation stage (42-45). Therefore, in whereas B splenocytes are mostly composed of the shortlived populations (40) . However, injection of the anti-mitotic order to determine the sensitivity of a pure immature B cells population, pre-B cells from BM were expanded in vitro in the drug HU results in a drastic depletion of all dividing cells and leads to elimination of splenic short-lived B lymphocytes and presence of the BM stromal cell line S17 and recombinant murine IL-7. When IL-7 is removed from the culture, the therefore in enrichment for long-lived populations (41). As can be seen in Fig. 5 , splenic B cells isolated from HU-treated proliferating pre-B cells differentiate into immature IgM ϩ IgD -B cells (Fig. 5A ). or untreated animals display the same sensitivity as peritoneal cells from the untreated animals. These results indicate thereSurprisingly, such immature B cells generated in vitro were considerably more resistant to anti-IgM-mediated suppression fore that life span does not correlate with sensitivity to sIgM ligation.
than were B cells isolated from BM ex vivo. Actually, as can be seen in Fig. 6(B) , B cells generated in vitro were as could suggest that these defined culture conditions lack putative factors that determine high levels of B cell sensitivity resistant to anti-IgM treatment as were splenic B cells. Thus the correlation between immaturity of the B cell population to sIgM-mediated signals in the BM environment. In order to address directly this hypothesis, in vitro differentiated B cells and the sensitivity to anti-Ig-mediated suppression of LPSdriven Ig secretion breaks down.
were incubated with bulk BM culture supernatants for 2 days and their sensitivity to sIgM ligation tested as before. Strikingly, Soluble factor(s) produced by total BM cells enhance B cells that have been exposed to factors produced by total sensitivity to sIgM ligation of in vitro generated B cells BM cells acquire a sensitive phenotype that translates as a 1 log difference in the concentration of anti-µ necessary to The observation that immature B cells, generated in vitro from expanded pre-B cells on cloned stromal cells and IL-7, are achieve a 50% inhibition (Fig. 7) . This result demonstrates that some BM soluble factor(s) can modulate B cell sensitivity considerably more resistant than BM B cells isolated ex vivo to sIgM ligation.
Discussion
This paper demonstrates major differences between BM and peripheral B cell populations in their sensitivity to surface IgM ligation (and cross-linking), as measured by the subsequent effects on the LPS-induced differentiation into high-rate Igsecreting cells. When B cells isolated ex vivo were compared, B cells from adult BM and newborn spleen were found to be 25-to 100-fold more sensitive to sIg cross-linking than mature peripheral B cells (isolated from spleen, peritoneal cavity or peripheral blood). These results confirm and extend previous studies (45), but are at variance with others (46) concluding on the inability of anti-Ig treatments to inhibit peritoneal B cells. Thus, although peritoneal B cells display the higher type of experiment (15, 16 ), but we show here that similar the threshold for Ig-mediated signaling in BM B cells and another that would make peripheral B cells less sensitive for signaling. The observation that in vitro generated immature B cells are considerably more resistant than ex vivo isolated BM B cells favors the former alternative. Furthermore, the activity of a sensitivity-inducing soluble factor(s) in BM cell cultures demonstrated here suggests its operation in vivo. An argument for the hypothesis above is contributed by the dose-response curves for inhibition which, being of a markedly broad appearance, indicate cellular heterogeneity in the response to a homogeneous ligand. There is indeed no difference in broadness between anti-µ-treated normal cells and the clonal populations of B6-Sp6 transgenic B cells treated with TNP-BSA. While some degree of cellular heterogeneity within each population may also concern sIgM levels (3), these differences are not sufficient to explain the differential sensitivity of BM and spleen. Furthermore, the present results show that some 30% of the BM B cells display the level of B cell sensitivity to sIgM-mediated signaling. This mechanism would provide the immune system with a capability of functionally regulating specific B cells all the way from their production in BM to their terminal differentiation into Ig-secreting cells. induced terminal differentiation and high-rate Ig secretion.
LPS lipopolysaccharide
The major finding in the present report is that the higher 
